|
PRINCETON, N.J.--(BUSINESS WIRE)--Mar 17, 2026--Astound, a recognized leader in WiFi, mobile, TV, and fiber‑optic solutions, today announced that Ettienne Brandt has joined the company as Chief …
more
3/17/26
|
|
CHICAGO--(BUSINESS WIRE)--Mar 17, 2026--Northern Trust Wealth Management has appointed Alyssa Quinlan as Head of Advisor Relationships & Strategic Partnerships. She will report to Global Head of …
more
3/17/26
|
|
LOS ANGELES, CA / ACCESS Newswire / March 17, 2026 / The Luminary 2026 Roundtable, a pioneering gathering at the intersection of film, AI, music, and cryptocurrency, successfully took place on …
more
3/17/26
|
|
BALTIMORE, March 17, 2026 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides …
more
MarketWise LLC
|
3/17/26
|
|
WASHINGTON--(BUSINESS WIRE)--Mar 17, 2026--MPOWER Financing, a mission-driven provider of education loans for high-potential students worldwide, today announced the launch of its Graduate Success …
more
3/17/26
|
|
TEL AVIV, Israel, March 17, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) today announced a commercial collaboration agreement with Blade Ranger Ltd. …
more
PRF Technologies Ltd.
|
3/17/26
|
|
Atlanta, GA, March 17, 2026 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (OTCQB: STAI) ("ScanTech AI" or the "Company"), a developer of advanced AI-powered security screening and imaging …
more
ScanTech AI Systems Inc.
|
3/17/26
|
|
MILWAUKEE, March 17, 2026 (GLOBE NEWSWIRE) -- Fiserv, Inc. (NASDAQ: FISV), a leading global provider of payments and financial services technology, today announced an agent bank partnership with …
more
Fiserv, Inc.
|
3/17/26
|
|
Regulatory milestone supports advancement of the SOTERIA Phase 2 basket trial evaluating PLX‑200 across multiple lysosomal storage disorders
PARAMUS, NJ, March 17, 2026 (GLOBE NEWSWIRE) -- …
more
Polaryx Therapeutics, Inc.
|
3/17/26
|
|
LOS ANGELES--(BUSINESS WIRE)--Mar 17, 2026--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, …
more
3/17/26
|
|
ESTERO, FL / ACCESS Newswire / March 17, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire"), wholly owned subsidiary, Buzz Bomb Caffeine Company, has appointed 25-year industry veteran …
more
3/17/26
|
|
DENVER--(BUSINESS WIRE)--Mar 17, 2026--Tax season is one of the most important financial moments of the year for Americans, and with the new auto loan interest deduction and evolving EV tax …
more
3/17/26
|
|
NEW YORK--(BUSINESS WIRE)--Mar 17, 2026--Genius Sports (NYSE: GENI) today announced a new multi-year integrity, technology and AI partnership with the Pac-12 Conference (“Pac-12”) to power the …
more
3/17/26
|
|
The last time Virginia won an NCAA Tournament game, Tony Bennett and the Cavaliers celebrated by cutting down the nets after defeating Texas Tech 85-77 in an overtime thriller for the national …
more
By STEVE REED
|
3/17/26
|
|
- Guardians of Culture & Arts Foundation launches international initiative to preserve endangered heritage through music, film, and cultural awareness -
LAS VEGAS, Nev., March 17, 2026 …
more
Guardians of Culture and Arts Foundation
|
3/17/26
|
|
CINCINNATI--(BUSINESS WIRE)--Mar 17, 2026--Managing day‑to‑day expenses while planning for the future has become increasingly complex for many households. Recent data shows only 63% of U.S. …
more
3/17/26
|
|
SAN FRANCISCO--(BUSINESS WIRE)--Mar 17, 2026--Gradient, the leading early stage venture capital firm designed for founders in artificial intelligence, announced it closed a new $220 million flagship …
more
3/17/26
|
|
Strengthens global IP and supports strategic positioning in the rapidly growing metabolic therapeutics marketRamat Gan, Israel, March 17, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE …
more
Can-Fite BioPharma Ltd.
|
3/17/26
|
|
SAN ANTONIO--(BUSINESS WIRE)--Mar 17, 2026--bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, …
more
3/17/26
|
|
- Global 4WARD Phase 3 Chronic Neutropenia Trial On Track to Complete Enrollment in Q3 2026 -- Positive Opinion from European Medicines Agency Recommending Marketing Authorization of Mavorixafor for …
more
X4 Pharmaceuticals
|
3/17/26
|